$ATEN
A10 Networks, Inc.

2015 Q4 Form 10-Q Financial Statement

#000158080815000044 Filed on November 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $53.95M $50.78M $43.43M
YoY Change 19.36% 16.92% 9.04%
Cost Of Revenue $13.30M $12.72M $11.75M
YoY Change 23.26% 8.19% 34.57%
Gross Profit $40.65M $38.06M $31.68M
YoY Change 18.13% 20.17% 1.88%
Gross Profit Margin 75.35% 74.96% 72.94%
Selling, General & Admin $35.77M $32.67M $29.79M
YoY Change 6.62% 9.65% 35.65%
% of Gross Profit 88.0% 85.82% 94.06%
Research & Development $13.30M $13.56M $12.34M
YoY Change -8.21% 9.88% 44.91%
% of Gross Profit 32.72% 35.63% 38.96%
Depreciation & Amortization $1.940M $2.100M $2.600M
YoY Change -30.22% -19.23% 44.44%
% of Gross Profit 4.77% 5.52% 8.21%
Operating Expenses $49.06M $46.70M $43.04M
YoY Change 2.12% 8.49% 33.83%
Operating Profit -$8.410M -$8.634M -$11.37M
YoY Change -38.3% -24.06% 962.52%
Interest Expense -$290.0K $151.0K $192.0K
YoY Change -78.83% -21.35% -86.28%
% of Operating Profit
Other Income/Expense, Net -$129.0K -$702.0K
YoY Change -81.62% -52.31%
Pretax Income -$8.970M -$8.763M -$12.07M
YoY Change -41.22% -27.4% 374.86%
Income Tax $250.0K $204.0K $233.0K
% Of Pretax Income
Net Earnings -$9.220M -$8.967M -$12.30M
YoY Change -42.45% -27.12% 347.58%
Net Earnings / Revenue -17.09% -17.66% -28.33%
Basic Earnings Per Share -$0.21
Diluted Earnings Per Share -$144.8K -$142.9K -$0.21
COMMON SHARES
Basic Shares Outstanding 63.34M shares 62.75M shares 59.91M shares
Diluted Shares Outstanding 62.75M shares 59.91M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.10M $100.5M $107.1M
YoY Change 6.75% -6.16% 252.3%
Cash & Equivalents $98.12M $100.5M $107.1M
Short-Term Investments
Other Short-Term Assets $5.100M $4.900M $4.900M
YoY Change 8.51% 0.0% 63.33%
Inventory $18.66M $17.57M $19.37M
Prepaid Expenses
Receivables $54.75M $41.49M $42.47M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $176.6M $164.5M $173.9M
YoY Change 3.06% -5.4% 113.88%
LONG-TERM ASSETS
Property, Plant & Equipment $8.903M $9.087M $11.84M
YoY Change -17.41% -23.23% 24.6%
Goodwill $72.00K
YoY Change 0.0%
Intangibles $795.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.531M $4.372M $4.629M
YoY Change -27.33% -5.55% 230.64%
Total Long-Term Assets $13.30M $13.46M $16.47M
YoY Change -14.95% -18.26% 30.68%
TOTAL ASSETS
Total Short-Term Assets $176.6M $164.5M $173.9M
Total Long-Term Assets $13.30M $13.46M $16.47M
Total Assets $189.9M $178.0M $190.4M
YoY Change 1.56% -6.51% 102.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.51M $8.182M $11.18M
YoY Change 16.83% -26.78% 110.85%
Accrued Expenses $27.76M $20.96M $19.99M
YoY Change 23.72% 4.83% -31.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $87.04M $73.49M $66.15M
YoY Change 23.14% 11.1% 17.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.414M $1.541M $1.974M
YoY Change -19.93% -21.94% -89.03%
Total Long-Term Liabilities $1.414M $1.541M $1.974M
YoY Change -19.93% -21.94% -95.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $87.04M $73.49M $66.15M
Total Long-Term Liabilities $1.414M $1.541M $1.974M
Total Liabilities $111.7M $97.02M $84.70M
YoY Change 23.53% 14.55% -14.7%
SHAREHOLDERS EQUITY
Retained Earnings -$223.7M -$214.5M -$165.8M
YoY Change 23.05% 29.38%
Common Stock $1.000K $1.000K $1.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $78.21M $80.94M $105.7M
YoY Change
Total Liabilities & Shareholders Equity $189.9M $178.0M $190.4M
YoY Change 1.56% -6.51% 102.72%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income -$9.220M -$8.967M -$12.30M
YoY Change -42.45% -27.12% 347.58%
Depreciation, Depletion And Amortization $1.940M $2.100M $2.600M
YoY Change -30.22% -19.23% 44.44%
Cash From Operating Activities -$4.240M $4.150M -$3.800M
YoY Change -75.09% -209.21% -42.68%
INVESTING ACTIVITIES
Capital Expenditures -$920.0K -$750.0K -$1.590M
YoY Change 27.78% -52.83% 62.24%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$920.0K -$750.0K -$1.590M
YoY Change 27.78% -52.83% 62.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.760M 910.0K 390.0K
YoY Change 8.66% 133.33% -101.91%
NET CHANGE
Cash From Operating Activities -4.240M 4.150M -3.800M
Cash From Investing Activities -920.0K -750.0K -1.590M
Cash From Financing Activities 2.760M 910.0K 390.0K
Net Change In Cash -2.400M 4.310M -5.000M
YoY Change -84.21% -186.2% -82.15%
FREE CASH FLOW
Cash From Operating Activities -$4.240M $4.150M -$3.800M
Capital Expenditures -$920.0K -$750.0K -$1.590M
Free Cash Flow -$3.320M $4.900M -$2.210M
YoY Change -79.63% -321.72% -60.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
aten Costs Related To Initial Public Offering Included In Accounts Payable And Accrued Liabilities
CostsRelatedToInitialPublicOfferingIncludedInAccountsPayableAndAccruedLiabilities
556000 USD
aten Costs Related To Initial Public Offering Included In Accounts Payable And Accrued Liabilities
CostsRelatedToInitialPublicOfferingIncludedInAccountsPayableAndAccruedLiabilities
366000 USD
CY2014Q3 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-510000 USD
aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-673000 USD
CY2015Q3 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
22000 USD
aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-167000 USD
CY2015Q2 aten Minimum Ownership Threshold
MinimumOwnershipThreshold
0.05
aten Proceeds From Issuance Initial Public Offering Net
ProceedsFromIssuanceInitialPublicOfferingNet
121037000 USD
aten Proceeds From Issuance Initial Public Offering Net
ProceedsFromIssuanceInitialPublicOfferingNet
0 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001580808
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
63335758 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
dei Entity Registrant Name
EntityRegistrantName
A10 Networks, Inc.
dei Trading Symbol
TradingSymbol
ATEN
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8994000 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8182000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54003000 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41492000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22435000 USD
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20960000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25744000 USD
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32263000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
278349000 USD
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
295400000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
408000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.13
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3246000 USD
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3227000 USD
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10679000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10485000 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15581000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14571000 shares
CY2014Q4 us-gaap Assets
Assets
186980000 USD
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2015Q3 us-gaap Assets
Assets
177959000 USD
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61377000 shares
CY2014Q4 us-gaap Assets Current
AssetsCurrent
171341000 USD
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63244000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61377000 shares
CY2015Q3 us-gaap Assets Current
AssetsCurrent
164500000 USD
CY2014Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
0 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20793000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107099000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91905000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100524000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
86306000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8619000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63244000 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11753000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32146000 USD
CY2015Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12715000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35102000 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8818000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
23655000 USD
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8529000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
23501000 USD
CY2014Q3 us-gaap Cost Of Services
CostOfServices
2935000 USD
us-gaap Cost Of Services
CostOfServices
8491000 USD
CY2015Q3 us-gaap Cost Of Services
CostOfServices
4186000 USD
us-gaap Cost Of Services
CostOfServices
11601000 USD
CY2014Q4 us-gaap Deferred Revenue
DeferredRevenue
57220000 USD
CY2015Q3 us-gaap Deferred Revenue
DeferredRevenue
66338000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
39256000 USD
CY2015Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
44352000 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
17964000 USD
CY2015Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
21986000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7337000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6784000 USD
CY2015Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6700000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17955000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8763000 USD
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-12071000 USD
CY2014Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2600000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7200000 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14447000 USD
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14459000 USD
CY2015Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
26600000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M13D
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
6993000 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5141000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16035000 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6892000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20122000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
31675000 USD
us-gaap Gross Profit
GrossProfit
102159000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
38063000 USD
us-gaap Gross Profit
GrossProfit
107229000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-32181000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
233000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
747000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
204000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
497000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4109000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1086000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4771000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11223000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4102000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1510000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
9670000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
9118000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6276000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-922000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-6832000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
18000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
197000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-104000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3303000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
97000 USD
CY2014Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2014Q3 us-gaap Interest Expense
InterestExpense
192000 USD
us-gaap Interest Expense
InterestExpense
904000 USD
CY2015Q3 us-gaap Interest Expense
InterestExpense
151000 USD
us-gaap Interest Expense
InterestExpense
382000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10779000 USD
CY2015Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8835000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
20701000 USD
CY2015Q3 us-gaap Inventory Net
InventoryNet
17566000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
9922000 USD
CY2015Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
8731000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
90415000 USD
CY2015Q3 us-gaap Liabilities
Liabilities
97021000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
186980000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
177959000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
70685000 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
73494000 USD
CY2014Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
910000 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-3103000 USD
CY2015Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
469000 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1939000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
105207000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3544000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5380000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2558000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13521000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7633000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-12304000 USD
us-gaap Net Income Loss
NetIncomeLoss
-18702000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-8967000 USD
us-gaap Net Income Loss
NetIncomeLoss
-32678000 USD
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12304000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19852000 USD
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8967000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-32678000 USD
CY2014Q4 us-gaap Noncurrent Assets
NoncurrentAssets
11777000 USD
CY2015Q3 us-gaap Noncurrent Assets
NoncurrentAssets
9989000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-702000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1577000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-129000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-549000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
43044000 USD
us-gaap Operating Expenses
OperatingExpenses
118537000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
46697000 USD
us-gaap Operating Expenses
OperatingExpenses
138861000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11369000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16378000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8634000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-31632000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5434000 USD
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3748000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4859000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
31000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-14000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5380000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2558000 USD
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
1150000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
20000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4372000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1766000 USD
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1541000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4732000 USD
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4918000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4399000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3238000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-229000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
306000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36524000 USD
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
41350000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10780000 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9087000 USD
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
4072000 USD
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
2213000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
52000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1575000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12342000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35416000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13562000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41542000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-181785000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-214463000 USD
CY2014Q3 us-gaap Revenues
Revenues
43428000 USD
us-gaap Revenues
Revenues
134305000 USD
CY2015Q3 us-gaap Revenues
Revenues
50778000 USD
us-gaap Revenues
Revenues
142331000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
31601000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
102140000 USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
34990000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
98837000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
43428000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
134305000 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
50778000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
142331000 USD
CY2014Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
11827000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
32165000 USD
CY2015Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
15788000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
43494000 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
24651000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
70189000 USD
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
25774000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
75258000 USD
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3538000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8314000 USD
CY2015Q3 us-gaap Share Based Compensation
ShareBasedCompensation
4608000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
13246000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
13900000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1535000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
922000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17394000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11084000 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10035000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.18
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.10
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
13179000 USD
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5592000 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
4.27
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
16950000 USD
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9633000 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.93
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.27
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.84
CY2015Q3 us-gaap Share Price
SharePrice
5.99
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y3M18D
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
7536000 USD
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
869000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
535000 shares
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
96565000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
80938000 USD
CY2014Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2554000 USD
CY2015Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
2753000 USD
CY2014Q3 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
0 USD
us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
-1150000 USD
CY2015Q3 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
0 USD
us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
0 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2200000 USD
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2400000 USD
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59913000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44538000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62753000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62009000 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
59913000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44538000 shares
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62753000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62009000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59913000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44538000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62753000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62009000 shares
us-gaap Year Founded
YearFounded
2004
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents and accounts receivable. Our cash and cash equivalents are invested in high-credit quality financial instruments with banks and financial institutions. Management believes that the financial institutions that hold our cash and cash equivalents are financially sound and, accordingly, are subject to minimal credit risk. Such deposits may be in excess of insured limits provided on such deposits.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our accounts receivable are unsecured and represent amounts due to us based on contractual obligations of our customers. We mitigate credit risk in respect to accounts receivable by performing periodic credit evaluations of our customers to assess the probability of accounts receivable collection based on a number of factors, including past transaction experience with the customer, evaluation of their credit history, limiting the credit extended and review of the invoicing terms of the contract. We generally do not require our customers to provide collateral to support accounts receivable. </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant customers, including distribution channel partners and direct customers, are those which represent more than 10% of our total revenue for each period presented or our gross accounts receivable balance as of each respective balance sheet date.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Those estimates and assumptions affect revenue recognition and deferred revenue, allowance for doubtful accounts, sales return reserve, valuation of inventory, contingencies and litigation, and determination of fair value of stock-based compensation. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from management&#8217;s estimates.</font></div></div>

Files In Submission

Name View Source Status
0001580808-15-000044-index-headers.html Edgar Link pending
0001580808-15-000044-index.html Edgar Link pending
0001580808-15-000044.txt Edgar Link pending
0001580808-15-000044-xbrl.zip Edgar Link pending
aten-20150930.xml Edgar Link completed
aten-20150930.xsd Edgar Link pending
aten-20150930_cal.xml Edgar Link unprocessable
aten-20150930_def.xml Edgar Link unprocessable
aten-20150930_lab.xml Edgar Link unprocessable
aten-20150930_pre.xml Edgar Link unprocessable
aten-2015930x10q.htm Edgar Link pending
exhibit3112015930.htm Edgar Link pending
exhibit3122015930.htm Edgar Link pending
exhibit3212015930.htm Edgar Link pending
exhibit3222015930.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending